REFERENCES
- Agathon A., Thisse C., Thisse B. The molecular nature of the zebrafish tail organizer. Nature 2003; 424: 448–452, [PUBMED], [INFOTRIEVE], [CSA]
- Alonzo-Aperte E., Ubeda N., Achon M., Perez-Miguelsanz J., Varela-Moreiras G. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 1999; 52: 750–756, [CSA]
- Amit S., Hatzubia A., Birman J., Andersen J. S., Ben-Shushan E., Mann M., Ben-Neriah Y., Alkalay I. Axin-mediated CKI phosphorylation of-βcatenin at Ser 45: A molecular switch for the Wnt pathway. Genes Dev. 2002; 16: 1066–1076, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arpino C., Brescianini S., Robert E., Castilla E. E., Cocchi G., Cornel M. C., de Vigan C., Lancaster P. A., Merlob P., Sumiyoshi Y., Zampino G., Renzi C., Rosano A., Mastroiacovo P. Teratogenic effects of antiepileptic drugs: Use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000; 41(11)1435–1443, [CSA], [CROSSREF]
- Behrens J., Kühl M. Wnt Signal Transduction Pathways: An Overview. Wnt signaling in Development, M. Kühl. Kluwer Academic/Plenum Publishers, New York 2003; 1–14
- Biernacki B., Bogdan W., Minta M. Effect of sodium valproate on rat embryo development in vitro. Bull. Vet. Inst. Pulawy 2000; 44: 201–205, [CSA]
- Bilder D., Graba Y., Scott M. P. Wnt and TGFβ signals subdivide the AbdA Hox domain during Drosophila mesoderm patterning. Development 1998; 125: 1781–1790, [PUBMED], [INFOTRIEVE], [CSA]
- Binkerd P. E., Rowland J. M., Nau H., Hendricks A. G. Evaluation of valproic (VPA) developmental toxicity and pharmacokinetics in Sprague Dawley rats. Fundam. Appl. Toxicol. 1988; 11(3)485–493, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Blaheta R. A., Nau H., Michaelis M., Cinatl J. Valproate and valproate-analogues: Potent tools to fight against cancer. Current Medicinal Chemistry 2002; 9: 1417–1433, [PUBMED], [INFOTRIEVE], [CSA]
- Bogumil B., Bogdan W., Minta M. Effect of sodium valproate on rat embryo development in vitro. Bull. Vet. Inst. Pulawy 2000; 44: 201–205, [CSA]
- Cadigan K. M., Nusse R. Wnt signaling: A common theme in animal development. Genes Dev. 1997; 11: 3286–3305, [PUBMED], [INFOTRIEVE], [CSA]
- Craig J., Morrison P., Morrow J., Patterson V. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate. Seizure 1999; 8: 253–254, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Detich N., Bovenzi V., Szyf M. Valproate induces replication independent DNA demethylation. J. Biol. Chem. 2003, [CSA]
- Drevets W. C. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 2001; 11: 240–249, [CSA]
- Drevets W. C., Price J. L., Simpson J. R., Jr., Todd R. D., Reich T., Vannier M., Raichle M. E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824–827, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Duncan S., Mercho S., Lopes-Cendes I., Seni M., Benjamin A., Dubeau F., Andermann F., Andermann E. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia 2001; 42: 750–753, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ehlers K., Sturjie H., Merker H. J., Nau H. Valproic acid-induced spinia bifida: A mouse model. Teratology 1992; 45(2)145–154, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Elmazar M. M.A., Nau H. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice. Teratogenesis, Carcinogenesis, and Mutagenesis 1992; 12: 203–210, [PUBMED], [INFOTRIEVE], [CSA]
- Elmazar M. M.A., Thiel R., Nau H. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice. Fundamental and Applied Toxicology 1991; 18: 389–394, [CSA], [CROSSREF]
- Faiella A., Wernig M., Consalez G. G., Hostick U., Hofmann C., Hustert E., Boncinelli E., Balling R., Nadeau J. H. A mouse model for valproate teratogenicity: Parental effects, homeotic transformations, and altered HOX expression. Hum. Mol. Genet. 2000; 9: 227–236, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Finnell R. H., Wlodarczyk B. C., Craig J. C., Piedrahita J. A., Bennett G. D. Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Amer. J. Med. Genetics 1997; 70: 303–311, [CSA], [CROSSREF]
- Fuller L. C., Cornelius S. K., Murphy C. W., Wiens D. J. Neural crest cell motility in valproic acid. Reprod. Toxicol. 2002; 16: 825–839, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goold R. G., Owen R., Gordon-Weeks P. R. Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein lB regulates the stability of microtubules in growth cones. J. Cell Sci. 1999; 112: 3373–3384, [PUBMED], [INFOTRIEVE], [CSA]
- Gould T. D., Manji H. K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 2002; 8: 497–511, [PUBMED], [INFOTRIEVE], [CSA]
- Gurvich N., Klein P. S. Lithium and valproic acid: Parallels and contrasts in diverse signaling contexts. Pharmacol. Ther. 2002; 96: 45–66, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hall A. C., Lucas F. R., Salinas P. C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 2000; 100: 525–535, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hall A. C., Brennan A., Goold R. G., Cleverley K., Lucas F. R., Gordon-Weeks P. R., Salinas P. C. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol. Cell Neurosci. 2002; 20: 257–270, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hansen D. K., Grafton T. F., Dial S. L., Gehring T. A., Siitonen P. H. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo. Teratology 1995; 52: 277–285, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Holmes L. B., Harvey E. A., Coull B. A., Huntington B. A., Khoshbin S., Hayes A. M., Ryan L. M. The Teratogenicity of Anti Convulsant Drugs. N. Engl. J. Med. 2001; 344: 1132–1135, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huristone F. L., Bethel H., Korving J., van Eeden F., Cuppen E., Ziukovic D., Pasterk R. H.A., Clevers H. The Wnt/β-catenin pathway regulates cardiac valve formation. Nature 2003; 425: 633–637, [CSA], [CROSSREF]
- Jamora C., DasGupta R., Kocieniewski P., Fuchs E. Links between signal transduction, transcription, and adhesion in epithelial bud development. Nature 2003; 422: 317–322, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kawagoe R., Kawagoe H., Sano K. Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways. Leukemia Res. 2002; 26: 495–502, [CSA], [CROSSREF]
- Kliecker C., Niehrs C. A morphogen gradient of Wnt/β-catenin signaling regulates anterioposterior neural patterning in Xenopus. Development 2001; 128: 4189–4201, [CSA]
- Li X., Bijur G. N., Jope R. S. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. BipolarDisord. 2002; 4: 137–144, [CSA], [CROSSREF]
- Lucas F. R., Salinas P. C. WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 1997; 192: 31–44, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Manji H. K., Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long term targets for mood stabilizers. Mol. Psychiatry 2002; 7: S46–S56, suppl. 1[PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Menegola E., Broccia M. L., Nau H., Prate M., Ricolfi R., Giavina E. Teratogenic effects of sodium valproate in mice and rats at mid-gestation and at term. Teratogen. Carcinogen. Mutagen. 1996; 16(2)97–108, [CSA], [CROSSREF]
- Mlodzik M. Epithelial planar cell polarity in Drosophila, M. Kühl. Kluwer Academic/Plenum Publishers, New York 2003; 90–101
- Moon R. T., Kohn A. D., DeFarrari G. V., Kaykas A. Wnt and β catenin signalling: Diseases and therapies. Nature Reviews Genetics 2004; 5: 691–701, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Narotsky M. G., Francis E. Z., Kavlock R. J. Developmental toxicity and structure-activity relationship of aliphatic acids, including dose-response assessment of valproic acid in mice and rats. Fundam. Appl. Toxicol. 1994; 22(2)251–265, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Naruse I., Collins M. D., Scott W. J., Jr. Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology 1988; 38(1)87–96, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Padmanabhan R., Shafiullah M. M. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Congenital Abnormalities 2003; 43: 29–40, [CSA]
- Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis—A look outside the nucleus. Science 2000; 287: 1606–1609, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Phiel C. J., Zhang F., Huang E. Y., Guenther M. G., Lazar M. A., Klein P. S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001; 276: 36734–36741, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pires-daSilva A., Sommer R. J. The evolution of signaling pathways in animal development. Nature Reviews Genetics 2003; 4: 39–49, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pourquié O. The segmentation clock: Converting embryonic time into spatial pattern. Science 2003; 301: 328–330, [CSA], [CROSSREF]
- Robert E., Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 1982; 2: 937, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stambolic V., Ruel L., Woodgett J. R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 1996; 6: 1664–1668, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Svensson K., Mattsson R., James T. C., Wentzel P., Pilartz M., MacLaughlin J., Miller S. J., Olsson T., Eriksson U. J., Ohlsson R. The paternal allele of the H19 gene is progressively silenced during early mouse development: The acetylation status of histones may be involved in the generation of variegated expression patterns. Development 1998; 125: 61–69, [PUBMED], [INFOTRIEVE], [CSA]
- Sztajnkrycer M. D. Valproic acid toxicity: Overview and management. J. Toxicology 2002; 40: 789–801, [CSA], [CROSSREF]
- Trotz M., Wegner C., Nau H. Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse. Life Sciences 1987; 41: 103–110, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wallingford J. B., Harland R. M. Neural tube closure requires Disheveled-dependent convergent extension of the midline. Development 2002; 129: 5815–5825, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang H., Malbon C. Wnt signaling, Ca2+, and cyclic GMP: Visualizing Frizzled functions. Science 2003; 300: 1529–1530, [PUBMED], [INFOTRIEVE], [CSA]
- Wegner C., Nau H. Diurnal variation of folate concentrations in mouse embryo and plasma: The protective effect of folinic acid on valproic acid-induced teratogenicity is time dependent. Reproductive Toxicology 1991; 5: 465–471, [PUBMED], [INFOTRIEVE], [CSA]
- Wegner C., Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: Implications for mechanism of teratogenesis. Neurology 1992; 42: 17–24, suppl. 5[PUBMED], [INFOTRIEVE], [CSA]
- Williams R. S., Cheng L., Mudge A. W., Harwood A. J. A common mechanism of action for three mood stabilizing drugs. Nature 2002; 417: 292–295, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yost C., Tones M., Miller J. R., Huang E., Kimelman D., Moon R. T. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by g1ycogen synthase kinase 3. Genes Devel. 1996; 10: 1443–1454, [PUBMED], [INFOTRIEVE], [CSA]